Menno Verhave

Publications

1. Pediatric Collagenous Gastritis: Clinical and Histologic Outcomes in a Large Pediatric Cohort. J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):513-519. View Abstract
2. Where Did the Blood Go?: A Meckel's Diverticulum Bleed Without Hematochezia or Melena. JPGN Rep. 2021 Nov; 2(4):e119. View Abstract
3. Pediatric Collagenous Gastroenterocolitis Successfully Treated with Methotrexate. Case Rep Pediatr. 2020; 2020:1929581. View Abstract
4. Fatal Central Nervous System Disease Following First Infliximab Infusion in a Child With Inflammatory Bowel Disease. Pediatr Neurol. 2016 Apr; 57:91-4. View Abstract
5. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):343-7. View Abstract
6. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. Inflamm Bowel Dis. 2011 Jan; 17(1):458-70. View Abstract
7. Regulatory regions in the rat lactase-phlorizin hydrolase gene that control cell-specific expression. J Pediatr Gastroenterol Nutr. 2004 Sep; 39(3):275-85. View Abstract
8. Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 3:S286-90. View Abstract
9. Regulation of rat lactase-phlorizin hydrolase (LPH) by C/EBP and HNF-3. 1999; 116:A567. View Abstract
10. Three distinct messenger RNA distribution patterns in human jejunal enterocytes. Gastroenterology. 1998 Jul; 115(1):86-92. View Abstract
11. Asymmetrical localization of mRNAs in enterocytes of human jejunum. J Histochem Cytochem. 1998 Mar; 46(3):335-43. View Abstract
12. Distinct mRNA distribution patterns in human jejunal enterocytes. 1998; 26:553. View Abstract
13. Demonstration of dual function enhancer and silencer activity in the CE-LPH1 region of the human lactase-phlorizin hydrolase (LPH) gene. 1998; 116:A559. View Abstract
14. Clinical Pediatric Gastroenterology. 1998; ; 229-233. View Abstract
15. Three distrinct mRNA distribution patterns in human jejunal enterocytes. 1998; 114:A892. View Abstract
16. Rat lactase-phlorizin hydrolase/human growth hormone transgene is expressed on small intestinal villi in transgenic mice. Gastroenterology. 1997 Sep; 113(3):844-55. View Abstract
17. Thoracoscopic esophagomyotomy for achalasia in a child. J Pediatr Gastroenterol Nutr. 1997 Feb; 24(2):215-7. View Abstract
18. Targeting of lactase-phlorizin hydrolase (LPH) and sucrase-isomaltase (SI) mRNAs to the apical domain of absorptive enterocytes of human jejunum. 1997; 112:A347. View Abstract
19. Identification of a negative cis-acting element in the rat lactase-phlorizin hydrolase (LPH) promoter. 1997; 112:A913. View Abstract
20. Lactase-phlorizin hydrolase (LPH) is degraded before its insertion into the microvillus membrane in rats prenatally exposed to ethanol. 1997; 112:A361. View Abstract
21. Immunosuppressive therapy for children with inflammatory bowel disease: a retrospective study with long-term follow-up. 1997; 112:A1079. View Abstract
22. Ceftriaxone choledocholithiasis. Pediatrics. 1996 Jul; 98(1):133-5. View Abstract
23. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1996 Apr; 22(3):296-302. View Abstract
24. Verification of the lactase site of rat lactase-phlorizin hydrolase by site-directed mutagenesis. Gastroenterology. 1995 Oct; 109(4):1234-40. View Abstract
25. Further characterization of the 5'-flanking region of the rat lactase-phlorizin hydrolase gene. Biochem Biophys Res Commun. 1995 Apr 26; 209(3):989-95. View Abstract
26. Transcriptional regulation of intestinal hydrolase biosynthesis during postnatal development in rats. Am J Physiol. 1994 Oct; 267(4 Pt 1):G584-94. View Abstract
27. Appropriate cell- and crypt/villus-specific expression of the rat lactase-phlorizin hydrolase gene in transgenic mice. 1994; 106:A244. View Abstract
28. Identification of positive and negative transcriptional regulatory regions in the rat lactase-phlorizin hydrolase gene, in Lentze MJ, Naim HY, and Grand RJ (eds). Mammalian Brush Border Membrane Proteins II. 1994; 26-29. View Abstract
29. Combined use of cyclosporin A (CSA) and azathioprine (AZA) in pediatric inflammatory bowel disease (IBD). 1994; 106:A23. View Abstract
30. Lactase: origin, gene expression, localization, and function. 1994; (14):781-805. View Abstract
31. Combined use of cyclosporin A (CSA) and azathioprine (AZA) in pediatric inflammatory bowel disease (IBD). 1994; 106:A23. View Abstract
32. Rat lactase-phlorizin hydrolase has a single main catalytic site with both ß-glucosidic and ß-galactosidic activities. 1994; 106:A1043. View Abstract
33. Identification and treatment of nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children. Am J Dis Child. 1993 Dec; 147(12):1280-1. View Abstract
34. Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. J Pediatr. 1993 Apr; 122(4):647-9. View Abstract
35. Identification of positive and negative transcriptional regulatory regions in the rat lactase-phlorizin hydrolase gene. 1993; 104:A287. View Abstract
36. Transcriptional regulation of lactase-phlorizin hydrolase and sucrase-isomaltase in rat intestine. 1993; 104:A630. View Abstract
37. Prevalence and treatment of gastroduodenal injury in children with juvenile rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. 1992; 102(4):A22. View Abstract
38. Expression of the rat intestinal lactase-phlorizin hydrolase gene along the proximal to distal axis and during postnatal development. 1992; (3):199A. View Abstract
39. Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem. 1991 Feb 25; 266(6):3882-7. View Abstract
40. Azathioprine in the treatment of children with inflammatory bowel disease. J Pediatr. 1990 Nov; 117(5):809-14. View Abstract
41. Somatostatin gene regulation: an overview. Metabolism. 1990 Sep; 39(9 Suppl 2):2-5. View Abstract
42. Regulation of somatostatin gene expression, in Schwartz T (ed). Neuropeptides and Their Receptors. 1990; 60-70. View Abstract
43. Regulation of expression of the human pre-pro VIP gene, in Wass J and Scanlon M (eds). Neuroendocrine Perspectives. 1989; 6. View Abstract
44. Regulation of somatostatin gene expression by phorbol esters. Presented at the American Gastroenterological Association 1989. 1989; 96:A527. View Abstract
45. Fos and jun cooperate to activate transcription of the human VIP gene. Society for Neuroscience Abstracts. 1989; (15):1124. View Abstract
46. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci U S A. 1988 Sep; 85(18):6662-6. View Abstract
47. The relevance of DNA mediated gene transfer in mammalian cells for neuroscience, in van Leeuwen FW, Buijs RM, Pool CW, and Pach O, (eds). Techniques in the Behavioual and Neural Sciences: Molecular Neuroanatomy. 1988; 3:79-94. View Abstract
48. Presented at the American Gastroenterological Association 1988. 1988; (94):A479. View Abstract
49. Characterization of a cyclic AMP responsive enhancer element in the human VIP gene. 1987. View Abstract
50. Efficacy and safety of azathioprine in children with IBD. Presented at the American Gastroenterological Association 1987. 1987; 92(5):1682. View Abstract
51. Mutational analysis of a cyclic AMP responsive element in the human VIP gene. 1987; 13(1):34. View Abstract
52. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system. J Clin Lab Immunol. 1982 Apr; 7(3):193-8. View Abstract
Show All Publications Show Fewer Publications